Parallax Volatility Advisers’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,500
Closed -$497K 3471
2022
Q1
$497K Buy
+1,500
New +$462K ﹤0.01% 1907
2020
Q4
Sell
-48,900
Closed -$13.5M 3290
2020
Q3
$13.5M Buy
48,900
+14,700
+43% +$4.23M 0.01% 865
2020
Q2
$8.26M Buy
34,200
+22,000
+180% +$4.42M 0.01% 880
2020
Q1
$1.78M Buy
+12,200
New +$2.03M ﹤0.01% 1282
2018
Q4
Sell
-15,000
Closed -$6.75M 4244
2018
Q3
$6.75M Buy
+15,000
New +$5.91M 0.01% 609
2016
Q1
Sell
-10,000
Closed -$903K 3971
2015
Q4
$903K Buy
+10,000
New +$849K ﹤0.01% 1319

Other funds holding ABMD

Parallax Volatility Advisers's ABMD Position: Q4 2020 in Review

Parallax Volatility Advisers sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 3,601 shares — an estimated $998K sold.

Parallax Volatility Advisers first reported a position in ABMD in Q2 2018 and held it in 7 quarters. The position peaked at $5.09M in Q1 2019. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Parallax Volatility Advisers reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 3,601 Abiomed Inc shares in Q4 2020, an estimated $998K.
  • Parallax Volatility Advisers first reported a position in Abiomed Inc in Q2 2018 and held it in 7 quarters.
  • Parallax Volatility Advisers's Abiomed Inc position peaked at $5.09M in Q1 2019.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.